Healthy volunteers help test new drug absorption
NCT ID NCT05923411
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how well two different tablet versions of an experimental drug (PF-07220060) enter the bloodstream. It also tested whether taking the drug with food or with a stomach acid medication (rabeprazole) changes absorption. About 113 healthy adults aged 18–65 took part. The results will help guide how the drug is given in future studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
New Haven Clinical Research Unit
New Haven, Connecticut, 06511, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common antifungal change how an experimental drug acts?
- Can a new injection help tackle obesity? a safety trial begins
- Will a new pill formula absorb the same? a trial puts it to the test
- Can a new drug tame Alzheimer's? early trial aims to find out
- Could sitting too much alter your nervous system?
- Could a cancer drug alter Metformin's effects? a trial investigates